ANI Pharmaceuticals (ANIP)

[auh2oman]

The Other Day ...

Posted an article written by a Pharmacist, Michele B. Kaufman, for The Rheumatologist, regarding the approval of Indomethacin last month for patients who are unable to swallow solid dosage forms. Indomethacin is approved to treat patients with rheumatoid arthritis, ankylosing spondylitis, severe osteoarthritis, acute painful shoulder (tendinitis and/or bursitis) and acute gouty arthritis.
This can only create an awareness among professionals in the field of Rheumatology that there is an 180 day market exclusivity granted to ANI Pharmaceuticals for the generic NSAID and they very well could be writing scripts for Cortrophin for their patients already or this approval, more importantly, could get those sales people in the door to increase those Cortrophin 1 ml vial size for the adjunctive treatment for this condition as well as promoting their exclusivity with Indomethacin.

BTW, Great Numbers Today !